Biomerica Inc (BMRA) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Biomerica Inc   (NASDAQ: BMRA)

Select the Financial Report: Select the Period:


Description of Biomerica Inc's Business Segments


Biomerica Inc. is a biomedical company that specializes in developing and manufacturing innovative diagnostic solutions, primarily focused on gastrointestinal and autoimmune diseases. Below is a detailed overview of the segments, products, and services that Biomerica offers, based on the known offerings in the industry.

Segments

1. Diagnostics: The core segment of Biomerica’s business revolves around developing diagnostic products. These products are designed to detect various health conditions through simple and reliable test methods.

2. Research and Development: This segment emphasizes innovation and the creation of new diagnostic technologies and products. The R&D team focuses on advancing techniques for improved accuracy and ease of use in clinical settings.

3. Manufacturing: Biomerica produces a variety of diagnostic test kits in compliance with strict quality standards. This segment includes both the production of proprietary products and the potential for contract manufacturing services.

Products

1. Diagnostic Test Kits: Biomerica offers a range of test kits that cover a variety of medical conditions.
- Gastrointestinal Testing: These kits are designed to diagnose conditions such as lactose intolerance, H. pylori infections, and other gastrointestinal disorders. They often use stool or breath tests for ease of use in home or clinical environments.
- Autoimmune Disease Testing: The company provides test kits aimed at identifying markers for autoimmune diseases, including conditions like rheumatoid arthritis and celiac disease. These tests help in the early diagnosis and management of these diseases.

2. Point-of-care Testing Products: These are designed for use in clinical settings, allowing healthcare providers to conduct tests and receive results quickly, often within minutes. These products cater to a variety of diseases and can be pivotal in emergency care scenarios.

3. Food Intolerance Tests: Biomerica has developed tests for food intolerances, which help individuals identify specific food sensitivities that may be contributing to their health issues.

4. Laboratory Services: Biomerica may offer additional laboratory services related to their diagnostic products, which could include processing samples and providing expert analysis of test results.

5. Research Products: This includes products intended for use in research settings, such as reagents and assays used in clinical studies to help discover better diagnostic methods or treatments.

Services

1. Customer Support and Education: Biomerica offers extensive customer support to help healthcare practitioners and patients understand its products. This may include training, troubleshooting, and technical assistance.

2. Regulatory Compliance Consultation: Given the nature of their products, Biomerica may offer services to help facilitate compliance with health regulations and standards, ensuring that their products meet industry requirements.

3. Contract Manufacturing: If applicable, Biomerica might provide contract manufacturing services to third-party companies looking to produce their own diagnostic assays or kits.

4. Scientific Collaboration: The firm may engage in partnerships with research institutions or clinical labs to develop new testing methodologies or refine existing products, thereby contributing to the broader scientific community.

Conclusion

Biomerica Inc. focuses on delivering innovative diagnostic solutions that are both easy to use and reliable. Through a combination of various segments, products, and services, the company aims to provide effective tools for diagnosing a range of health issues, enhancing patient care, and supporting healthcare professionals in their treatment efforts. The ongoing commitment to research and development further positions Biomerica as a proactive player in the biomedical landscape, continually introducing novel solutions to meet emerging healthcare needs.


Composition of Biomerica Inc Revenues by Segments

 
Clinical Lab    127.51 % of total Revenue
Middle East    1.71 % of total Revenue

Q4 three months ended (May 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Clinical Lab 1.12 127.51 %
Middle East 0.02 1.71 %
Total 0.88 100 %




Q4 three months ended (May 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Clinical Lab - 79.87 %
Middle East - -91.23 %
Total -83.51 % -11.25 %




Q4 three months ended (May 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.15 -




Q4 three months ended (May 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Biomerica Inc Divisions, Sales by Country

 
Clinical Lab   Clinical Lab Segment contribution to total sales 59.89 % of total Revenue
Middle East   Middle East Segment contribution to total sales 11.86 % of total Revenue
Contract Manufacturing   Contract Manufacturing Segment contribution to total sales 20.15 % of total Revenue
Europe   Europe Segment contribution to total sales 24.42 % of total Revenue
Asia   Asia Segment contribution to total sales 32.35 % of total Revenue
North America   North America Segment contribution to total sales 31.22 % of total Revenue
Over The Counter   Over The Counter Segment contribution to total sales 19.75 % of total Revenue
Physicians Office   Physicians Office Segment contribution to total sales 0.21 % of total Revenue
South America   South America Segment contribution to total sales 0.15 % of total Revenue


Twelve months ended 2025
BMRA s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Clinical Lab 3.18 59.89 %
Middle East 0.63 11.86 %
Total 5.31 100 %
Contract Manufacturing 1.07 20.15 %
Europe 1.30 24.42 %
Asia 1.72 32.35 %
North America 1.66 31.22 %
Over The Counter 1.05 19.75 %
Physicians Office 0.01 0.21 %
South America 0.01 0.15 %


Twelve months ended 2025
BMRA s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -4.97 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Clinical Lab -1.7 % -
Middle East -21.25 % -
Total -1.92 % -
Contract Manufacturing 44.4 % -
Europe -9.81 % -
Asia -8.67 % -
North America 29.03 % -
Over The Counter -26.44 % -
Physicians Office -8.33 % -
South America -27.27 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.